Search Results 2551-2560 of 18331 for rheumatoid arthritis

  1. COVID-19 update / healthy mindset for back to school / reversing heart disease / regenerative medicine - Mayo Clinic News Network

    Arthritis / reversing heart disease / regenerative medicine. Arthritis / reversing heart disease / regenerative medicineDec. 12, 2020. By Jennifer O'Hara ...

  2. Orthopedics/Sports - Mayo Clinic News Network

    Mayo Clinic Minute: Reducing thumb arthritis pain featured image. Mayo Clinic Minute: Reducing thumb arthritis pain. Sonya Goins. July 24, 2024. First · 1 · 2 ...

  3. Publications - Christian Hanna, M.D., M.S. - Mayo Clinic

    Hypoxia-inducible factor-2alpha and TGF-beta signaling interact to promote normoxic glomerular fibrogenesis. Am J Physiol Renal Physiol. 2013 Nov 1; 305 (9): ...

  4. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

    ... factor for risk group allocation; however, this has largely been replaced by the detection of minimal residual disease (MRD). Other than age and white blood ...

  5. Knee Biologic Preservation: Functional and Clinical Outcome

    Arthritis; Infection. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...

  6. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

    Hematopoietic growth factors: ≥ 14 days after the last dose of a long-acting growth factor (e.g., Neulasta) or 7 days for short-acting growth factor; for ...

  7. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

    ... factor [G-CSF], granulocyte macrophage colony-stimulating factor [GM-CSF], or recombinant erythropoietin) within 4 weeks prior to study treatment. Patient ...

  8. Publications - Megan N. Wasson, D.O. - Mayo Clinic

    Is Hysterectomy a Risk Factor for Urinary Retention? A Retrospective Matched Case Control Study. J Minim Invasive Gynecol. 2020 Nov - Dec; 27 (7):1598-1602 ...

  9. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...

  10. Publications - Holly L. Geyer, M.D. - Mayo Clinic

    Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition. Cancer Med. 2020 Nov; 9(22):8301-8309 ...